Home › NDC Lookup › Ingredients › Ammonia 15% Smelling Salts › 85248-0028-01
🫁image loading
(from DailyMed)

WXMX Smelling Salts Ammonia 15% 15 g/100g Inhalant, 50 g — NDC 85248-028-01 (Billing 85248-0028-01)

by Jiangxi Yudexi Pharmaceutical Co., LTD · 50 g in 1 BOTTLE

This is a package of 50 g of WXMX Smelling Salts Ammonia 15% 15 g/100g Inhalant from Jiangxi Yudexi Pharmaceutical Co., LTD, no longer marketed (first marketed Jan 2026), no longer in the FDA NDC Directory. It is this product's only package size.

NDC 85248-0028-01
🏷️ FDA NDC (as labeled) 85248-028-01 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Sep 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 85248-028-01
Product NDC 85248-028
11-digit billing NDC 85248002801
RxCUI 1299889
UNII 5138Q19F1X
Application # M011
SPL Set ID 49927820-1862-4792-e063-6294a90acf9e
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Sep 2026)
Marketing start 2026-01-30
Route RESPIRATORY (INHALATION)
Dosage form INHALANT
Substance AMMONIA
Quick answers
  • RxCUI (RxNorm): 1299889
Why two NDCs? The FDA registers this code as 85248-028-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 85248-0028-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Radioactive Diagnostic Agent class.

Pharmacologic class Radioactive Diagnostic Agent
Drug family (ATC) Other cardiovascular system diagnostic radiopharmaceuticals
How it works Radiopharmaceutical Activity
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

WXMX Smelling Salts is an inhalant product containing 15% ammonia that is inhaled through the nose. Ammonia vapors are commonly used in smelling salts to stimulate the respiratory system and reflexes through nasal irritation. This is an over-the-counter monograph drug, meaning it is marketed under established FDA guidelines for this product category rather than through individual product approval.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
85248-0028-01 You're viewing this Main listing 50 g in 1 BOTTLE 2026-01-30 — Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
First Aid Only Ammonia Inhalants .045 g/.3mL 00924-5401-01 Acme 10 ampules — — FDA listed —
Ammonia Inhalants .045 g/.3mL 46414-3333-02 James 100 ampules — — FDA listed —
Ammonia Inhalants .05 g/.33mL 67777-0251-01 Dynarex 33 ml — — FDA listed —
Ammonia .15 g/g 68599-7100-01 McKesson 15 g — — Discontinued —
ammonia inhalants .045 g/.3mL 82749-0150-02 Epic 100 ampules — — FDA listed —
Allbizr Iron Shogun Smelling Salts 15 g/100g 85209-0011-01 Hong 65 g — — FDA listed —
Lepnuns SMELLING SALTS 15 g/100g 85248-0021-01 Jiangxi 40 g — — Discontinued —
WXMX Smelling Salts 15 g/100gthis 85248-0028-01 Jiangxi 50 g — — Discontinued —
Botasun Smelling Salts 15 g/100g 85248-0035-01 Jiangxi 40 g — — Discontinued —
Flobow SMELLING SALTS 15 g/100g 85248-0098-01 Jiangxi 40 g — — Discontinued —
Serynth Smelling Salts 15 g/100g 85248-0105-01 Jiangxi 40 g — — Discontinued —
Sylvirene Smelling Salts 15 g/100g 85248-0140-01 Jiangxi 40 g — — Discontinued —
Reinreude Smelling Salts 15 g/100g 85248-0152-01 Jiangxi 40 g — — Discontinued —
Ottffss Smelling Salts 15 g/100g 85248-0179-01 Jiangxi 40 g — — Discontinued —
Nrmrqz SMELLING SALTS 15 g/100g 85248-0182-01 Jiangxi 40 g — — Discontinued —
LukGain SMELLING SALTS 15 g/100g 85248-0186-01 Jiangxi 40 g — — Discontinued —
Rhinoost SMELLING SALTS 15 g/100g 85248-0193-01 Jiangxi 50 g — — Discontinued —
Unikinesys SMELLING SALTS 15 g/100g 85248-0197-01 Jiangxi 50 g — — Discontinued —
Hoxlbin SMELLING SALTS 15 g/100g 85248-0198-01 Jiangxi 50 g — — Discontinued —
smelling salts SMELLING SALTS 15 g/100g 85248-0225-01 Jiangxi 40 g — — Discontinued —
TideFresh SMELLING SALTS 15 g/100g 85248-0231-01 Jiangxi 40 g — — Discontinued —
Thitfam Smelling Salts 15 g/100g 85248-0234-01 Jiangxi 30 g — — Discontinued —
ANTYZE Smelling Salts 15 g/100g 85590-0001-01 Shenzhen 30 g — — FDA listed —
Gluvelop SMELLING SALTS 15 g/100g 85590-0002-01 Shenzhen 30 g — — FDA listed —
UpSniff Smelling Salts 15 g/100g 85590-0003-01 Shenzhen 30 g — — FDA listed —
TEHCIN smelling salts 15 g/100g 85593-0117-01 Guangzhou 60 g — — Discontinued —
Summit Smelling Salts 15 g/100g 85764-0001-01 Washburn 40 g — — FDA listed —
smelling salts 15 g/100g 85765-0001-01 Shenzhen 30 g — — Discontinued —
smelling salts 15 g/100g 85765-0002-01 Shenzhen 1 bottle — — Discontinued —
smelling salts .15 g/g 85765-0003-01 Shenzhen 50 g — — Discontinued —
ammonia inhalants 15 g/100mL 85813-0003-01 Direct 50 ampules — — FDA listed —
Smelling Salts 15 g/100g 85821-0001-01 Shenzhen 30 g — — FDA listed —
Smelling Salts .15 g/g 85839-0005-01 Shenzhen 30 g — — FDA listed —
Allbiz Sealed Oni Smelling Salts .15 g/g 85920-0001-01 Foshan 50 g — — Discontinued —
Allbiz Sealed Oni Smelling Salts 15 g/100g 85920-0002-01 Foshan 40 g — — Discontinued —
Allbiz Mint Oni Smelling Salts 15 g/100g 85920-0003-01 Foshan 65 g — — Discontinued —
Smelling Salt 4.5 g/30g 85999-0001-01 Nanning 30 g — — Discontinued —
Smelling Salt 15 g/100g 87055-0001-01 Guangzhou 30 g — — Discontinued —
Smelling Salt 4.5 g/30g 87175-0001-01 Guangzhou 30 g — — FDA listed —
Palinoia Ammonia Inhalant 15 g/100g 87176-0002-02 Centeroblivion 1 bottle — — Discontinued —
Smelling Salt 4.5 g/30g 87248-0001-01 Shenzhen 30 g — — FDA listed —
Snap Labs Ammonia Inhalants 150 mg/mL 87270-0001-01 Brined 1 jar — — FDA listed —
Snap Labs 20-Count Ammonia Inhalants 150 mg/mL 87270-0002-01 Brined 1 jar — — FDA listed —
Snap Labs Ammonia Inhalants 150 mg/mL 87270-0003-02 Brined 1 jar — — FDA listed —
Snap Labs Ammonia Inhalants 150 mg/mL 87270-0004-01 Brined 1 jar — — FDA listed —
Smelling Salts 15 g/100g 87585-0001-01 Guangzhou 40 g — — FDA listed —
Smelling Salts 15 g/100g 87592-0001-01 Shenzhen 30 g — — FDA listed —
Smelling Salts 15 g/100g 87711-0001-01 Hodayfa 30 g — — FDA listed —
Laioacdl Smelling Salts 15 g/100g 87786-0011-01 Wenzhou 40 g — — Discontinued —
Hymyyxgs Smelling Salts 15 g/100g 87786-0012-01 Wenzhou 40 g — — Discontinued —
Lucksky Smelling Salts 15 g/100g 87786-0041-01 Wenzhou 40 g — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Jan 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

We could not link this NDC to a current FDA Structured Product Label. An inactive-ingredient list is therefore not available from this source.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerJiangxi Yudexi Pharmaceutical Co., LTD
FDA applicationM011 (OTC MONOGRAPH DRUG)
Labeler code85248
First marketedJan 2026
Product typeHuman Otc Drug
Portfolio214 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 11 words ▾

Use For the temporary stimulation of the senses to restore alertness.

⏱️ Dosage and Administration 57 words ▾

Directions Hold bottle 10-15 cm (4-6 inches) from nostrils. Inhale gently. Do not place directly inside the nostrils. Do not inhale for more than 2 seconds per use. Do not use more than once every 60 minutes. Do not use more than 10 times per day. Use only as needed. If symptoms persist, consult a healthcare professional.

⚠️ Warnings 76 words ▾

Warnings For inhalation use only. Do not ingest or apply to skin. Avoid direct contact with eyes.

If contact occurs, rinse thoroughly with water for 15 minutes. Use only as directed. Misuse may be harmful.

Use in a well-ventilated area. Do not use in enclosed spaces. Prolonged exposure may cause irritation.

Discontinue use if discomfort occurs. Possible side effects include nasal irritation, coughing, or shortness of breath. If symptoms persist, discontinue use and consult a doctor.

📦 Storage and Handling 32 words ▾

Other information Store in a cool, dry place at 15-25°C (59-77°F). Avoid freezing, excessive heat above 40°C (104°F), and direct sunlight. Do not use if safety seal under cap is broken .

🧪 Active Ingredient 4 words ▾

Active Ingredient Ammonia 15%

🧪 Inactive Ingredients 8 words ▾

Inactive ingredients Alcohol, Ammonium Carbonate , Peppermint Oil.

🎯 Purpose 2 words ▾

Purpose Inhalant

📄 Do Not Use 31 words ▾

Do not use If you have respiratory conditions such as asthma or emphysema. If you have heart disease or high blood pressure. If you are allergic to ammonia or strong odors.

📄 Ask a Doctor Before Use If 21 words ▾

Ask Doctor Stop use and ask a doctor if irritation or rash occurs. These may be signs of a serious condition.

📄 When Using This Product 40 words ▾

When Using Avoid contact with eyes, ears, and mouth. If product gets into eyes, rinse thoroughly with water for 15 minutes. Stop use and ask a doctor if irritation or rash occurs. These may be signs of a serious condition.

📄 Stop Use and Ask a Doctor If 21 words ▾

Stop Use Stop use and ask a doctor if irritation or rash occurs. These may be signs of a serious condition.

📄 Keep Out of Reach of Children 26 words ▾

Keep Oot Of Reach Of Children Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately at 1-800-222-1222.

📄 Package Label / Principal Display Panel 4 words ▾

PRINCIPAL DISPLAY PANEL 15

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Jiangxi Yudexi Pharmaceutical Co., LTD is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 85248-0027-01 · Jiangxi 85248-0029-01 · Jiangxi →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.